Pharmaceutical companies invested more than $22 billion in patient support programs in 2024, according to Zelthy’s 2026 analysis of the patient support landscape. Yet only 3 to 8% of eligible patients use them. For a category built specifically to help patients start and stay on treatment, that gap is hard to ignore. Awareness remains one […]
Where AI Doesn’t Belong In 2025, Snow published ‘Read This Before You Automate Patient Content,’ making the case that privacy must come first in patient storytelling, and that no amount of speed is worth risking patient trust. This is a mandate we will never lose sight of, no matter how sophisticated technology and AI become. […]
Every September, Snow celebrates Patient Appreciation Month, dedicated to thanking the patients who share their experiences, perspectives, and time with us. There is no single way to make an impact. From sharing a personal story to supporting a fellow Ambassador or exploring opportunities to get involved, every contribution helps make our community stronger. It started […]
Eleven months ago, an FDA warning letter was a rare event. Enforcement letters had fallen from more than 130 a year in the late 1990s to just five in all of 2024. Then came last September, when the FDA’s Office of Prescription Drug Promotion (OPDP) sent more than 60 warning and untitled letters in a […]